DAL shareholder files Form 144 to sell 23,323 NYSE-listed shares

Rhea-AI Filing Summary

Form 144 notice filed for a proposed secondary sale. A shareholder plans to sell up to 23,323 shares of common stock, with an aggregate market value of $1,453,652.18, through Fidelity Brokerage Services LLC. The approximate sale date listed is 10/21/2025 and the shares are listed on the NYSE.

The shares were acquired on 10/21/2025 via cash exercise of stock options originally granted on 02/09/2017 (2,503 shares), 02/08/2018 (9,710 shares), and 02/06/2019 (11,110 shares). Shares outstanding were 652,962,768. This filing is a notice of proposed sale; actual transactions may vary.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	23323	1453652.18	652962768	10/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/21/2025	Options Granted - 02/09/2017	Issuer			2503	10/21/2025	Cash
Common	10/21/2025	Options Granted - 02/08/2018	Issuer			9710	10/21/2025	Cash
Common	10/21/2025	Options Granted - 02/06/2019	Issuer			11110	10/21/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does DAL's Form 144 filing disclose?

It discloses a proposed sale of up to 23,323 common shares with an aggregate market value of $1,453,652.18.

When is the approximate sale date in DAL's Form 144?

The filing lists an approximate sale date of 10/21/2025.

Which broker is named in DAL's Form 144?

The broker is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.

On which exchange are the shares listed according to the filing?

The filing names the NYSE as the securities exchange.

How were the shares acquired per the Form 144?

They were acquired on 10/21/2025 via cash exercise of options granted on 02/09/2017, 02/08/2018, and 02/06/2019.

How many shares are outstanding as stated in the filing?

The filing lists 652,962,768 shares outstanding.

What are the per-grant share amounts tied to the option exercises?

The filing lists 2,503, 9,710, and 11,110 shares tied to the respective grant dates.